JAMA Neurology Author Interviews

Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy

GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Optimal Delay Time to Initiate Anticoagulation After AF-Associated Ischemic Stroke

Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage

Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine

β-Blocker Use and Delayed Onset and Progression of Huntington Disease

Alzheimer Disease as a Clinical-Biological Construct

Perceived CTE in Former Professional Football Players

Localized Nicardipine Release Implants for Prevention of Vasospasm

Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events

Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation

Association of New-Onset Seizures With SARS-CoV-2 Vaccines

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

Posttraumatic Epilepsy and Dementia Risk

Risk of Stroke and Myocardial Infarction Among Initiators of Triptans

Risk Factors for Young-Onset Dementia in the UK Biobank

Endovascular Therapy Outcomes by ASPECTS and Infarct Core Volume in Patients With Large Infarct

Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis

Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease

Neuropathologic and Clinical Findings in Athletes With Repetitive Head Impacts

Dementia Risk and Disadvantaged Neighborhoods

Automated Interpretation of Clinical Electroencephalograms Using Artificial Intelligence

Risk of Parkinson Disease Among Camp Lejeune Veterans

Prenatal Exposure to Antiseizure Medication and Psychiatric Disorders

Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors

Optimal Intensity and Duration of Walking Rehabilitation in Patients With Chronic Stroke

Endovascular Thrombectomy vs Medical Management Beyond 24 Hours of Last Known Well

Autoimmune Encephalitis Misdiagnosis in Adults

Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease

Cancer Risk in Children of Mothers With Epilepsy and High-Dose Folic Acid Use During Pregnancy

Association of Neurocritical Care With Outcomes for Adults With Brain Injury

Efficacy of Benzodiazepines or Antihistamines for Patients With Acute Vertigo

A Conversation With Dr Kirsten Bibbins-Domingo, JAMA’s New Editor in Chief

Structural Inequities for Historically Underserved Communities in the Adoption of Stroke Certification in the US

Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability

Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19

Early Posttraumatic Seizures and Moderate to Severe Traumatic Brain Injury

Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy

Assessment of Erenumab Safety and Efficacy in Migraine With and Without Aura

Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Probable Dementia With Lewy Bodies

Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up

Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis

Risk of Rupture After Intracranial Aneurysm Growth

Seizure Prophylaxis After Spontaneous Intracerebral Hemorrhage

Tau PET as a Prognostic Marker

Association of Nitrogen Dioxide and Other Air Pollution Exposures With the Risk of Parkinson Disease

Effect of High-Frequency (10 kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy

Reperfusion Treatment and Stroke Outcomes in Hospitals with Telestroke Capacity